Bioceres Crop Solutions Corp. (NASDAQ:BIOX) Receives Average Recommendation of “Buy” from Analysts

Shares of Bioceres Crop Solutions Corp. (NASDAQ:BIOX) have been assigned a consensus recommendation of “Buy” from the six analysts that are covering the company, MarketBeat.com reports. Four equities research analysts have rated the stock with a buy recommendation and two have assigned a strong buy recommendation to the company. The average 1-year target price among brokers that have issued ratings on the stock in the last year is $12.13.

BIOX has been the topic of several recent analyst reports. Lake Street Capital decreased their price objective on shares of Bioceres Crop Solutions from $25.00 to $13.00 and set a “buy” rating on the stock in a report on Wednesday, September 11th. Oppenheimer cut their price target on shares of Bioceres Crop Solutions from $16.00 to $13.00 and set an “outperform” rating on the stock in a research note on Monday, October 21st. Canaccord Genuity Group lowered their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Finally, Roth Mkm cut their target price on shares of Bioceres Crop Solutions from $15.00 to $13.00 and set a “buy” rating on the stock in a research note on Wednesday, September 11th.

Hedge Funds Weigh In On Bioceres Crop Solutions

Hedge funds have recently added to or reduced their stakes in the stock. Stifel Financial Corp lifted its holdings in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock valued at $321,000 after purchasing an additional 10,224 shares during the last quarter. Ping Capital Management Inc. purchased a new position in shares of Bioceres Crop Solutions during the second quarter worth approximately $448,000. Sumitomo Mitsui Trust Holdings Inc. acquired a new position in Bioceres Crop Solutions in the second quarter valued at $472,000. Dimensional Fund Advisors LP raised its holdings in shares of Bioceres Crop Solutions by 9.5% in the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock valued at $688,000 after buying an additional 5,341 shares during the last quarter. Finally, Long Focus Capital Management LLC boosted its stake in shares of Bioceres Crop Solutions by 19.9% during the second quarter. Long Focus Capital Management LLC now owns 280,547 shares of the company’s stock worth $3,145,000 after buying an additional 46,647 shares during the period. 17.68% of the stock is currently owned by hedge funds and other institutional investors.

Bioceres Crop Solutions Trading Down 0.2 %

Shares of BIOX opened at $6.32 on Friday. The company has a current ratio of 1.27, a quick ratio of 0.87 and a debt-to-equity ratio of 0.37. The firm has a 50-day moving average price of $6.73 and a 200 day moving average price of $8.82. Bioceres Crop Solutions has a 12-month low of $5.71 and a 12-month high of $14.05. The firm has a market capitalization of $397.21 million, a P/E ratio of 316.16 and a beta of 0.51.

Bioceres Crop Solutions (NASDAQ:BIOX) last posted its earnings results on Monday, November 11th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.02 by ($0.11). Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. The business had revenue of $92.60 million for the quarter, compared to analyst estimates of $117.15 million. During the same period last year, the business earned ($0.07) EPS. Sell-side analysts forecast that Bioceres Crop Solutions will post 0.12 EPS for the current year.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.